Fresh Use of Targeted Therapy Advances Treatment of Early HER2- Positive Breast Cancer
17th Nov 2006, 01:00 GMT
The news that the world's first targeted therapy, trastuzumab (Herceptin), is now available for many women with early-stage HER2-positive breast cancer "highlights a truly significant advance in the management of breast cancer," says Edith Perez, ...
Latest news from U.S. Newswire Releases:
- National Constitution Center Announces Peter Jennings Project Board of Advisors
- Olmert Doesn't Represent Jewry Says Orthodox Spokesman Anti Zionist Jews to Protest Arrival of 'Israeli' Prime Minister in Washington
- U.S. Holocaust Museum to Project Wall-Sized Images of Genocide in Darfur onto Building Exterior in Week-Long Event
- Census Bureau Jobs Available in the Fayetteville Area, Pay Starts at $11.50 Per Hour
- Independent Oil and Natural Gas Investment Research Report Published by Altenews
- Small Business Group Claims Success in Media Campaign Supporting Senator-Elect Corker, Senator Kyl, Rep.-elect Bachmann
- New Food Seal Sets Highest Standards for Humane Treatment of Farm Animals
- Illinois Recycling Association Teams with TerraCycle Plant Food(tm) on Statewide Fundraising Program
- Greens Defeat Pombo by Running Away From Green Issues
- U.S. Census Bureau Daily Feature for Nov. 14: Circling the Globe